News Release

Predicting nasopharyngeal carcinoma patient response to radiation therapy

Peer-Reviewed Publication

JCI Journals

Nasopharyngeal carcinoma (NPC) affects cells lining the nasopharynx. The majority of NPC cases can be cured by radiation therapy, however ~20% are resistant to radiation treatment.

In this issue of the Journal of Clinical Investigation, Yu-Sun Chang and colleagues at Chang Gung University sought to find a way to predict which individual cases of NPC would be sensitive to radiation therapy. The authors compared the levels of various serum factors between NPC patients that responded to radiation therapy and patients that were resistant to therapy. Patients that did not respond to radiation therapy had higher serum levels of the IL-6 family cytokine leukemia inhibitory factor (LIF), and that LIF levels were predictive of NPC patient response to radiation therapy. The researchers further demonstrated that LIF itself promotes NPC.

In the companion commentary, Micah Luftig from the Duke University School of Medicine discusses the implications of LIF as a predictor of NPC resistance to radiation therapy.

###

TITLE: Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance

AUTHOR CONTACT: Yu-Sun Chang
Chang Gung University, Kwei-shan, Taoyuan, , TWN
Phone: 886-3-211-8800 Ext 5131; Fax: 886-3-211-8683; E-mail: ysc@mail.cgu.edu.tw

View this article at: http://www.jci.org/articles/view/63428?key=191243bd59aa6288820e

ACCOMPANYING COMMENTARY

TITLE: Heavy LIFting: tumor promotion and radioresistance in NPC

AUTHOR CONTACT: Micah Luftig
Duke Univeristy School of Medicine, Durham, NC, USA
Phone: (919) 668-3091; Fax: ; E-mail: micah.luftig@duke.edu

View this article at: http://www.jci.org/articles/view/73416?key=15a7795d9596b6418f40


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.